{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:19:45Z","timestamp":1790108385712,"version":"4.0.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Singhealth","award":["SRG-NIG #08\/2017"],"award-info":[{"award-number":["SRG-NIG #08\/2017"]}]},{"DOI":"10.13039\/100004331","name":"Johnson and Johnson","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s11255-020-02674-w","type":"journal-article","created":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T02:02:41Z","timestamp":1602036161000},"page":"803-812","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Chlorhexidine-impregnated sponge dressing for prevention of catheter exit-site infection in peritoneal dialysis patients: a pilot study"],"prefix":"10.1007","volume":"53","clinical-trial-number":[{"clinical-trial-number":"nct03406520","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6597-7267","authenticated-orcid":false,"given":"Htay","family":"Htay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason Chon Jun","family":"Choo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine M.","family":"Pascoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathini","family":"Jayaballa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth Ley","family":"Oei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li Choo","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sin Yan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjorie Wai Yin","family":"Foo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,6]]},"reference":[{"issue":"10","key":"2674_CR1","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1093\/ndt\/gfh386","volume":"19","author":"D Kavanagh","year":"2004","unstructured":"Kavanagh D, Prescott GJ, Mactier RA (2004) Peritoneal dialysis-associated peritonitis in Scotland (1999\u20132002). Nephrol Dial Transplant 19(10):2584\u20132591","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"2674_CR2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.2215\/CJN.05380518","volume":"14","author":"KE Manera","year":"2019","unstructured":"Manera KE, Johnson DW, Craig JC, Shen JI, Ruiz L, Wang AY-M et al (2019) Patient and caregiver priorities for outcomes in peritoneal dialysis. Clin J Am Soc Nephrol. 14(1):74\u201383","journal-title":"Clin J Am Soc Nephrol."},{"issue":"3","key":"2674_CR3","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.kint.2019.03.015","volume":"96","author":"KE Manera","year":"2019","unstructured":"Manera KE, Tong A, Craig JC, Shen J, Jesudason S, Cho Y et al (2019) An international Delphi survey helped develop consensus-based core outcome domains for trials in peritoneal dialysis. Kidney Int 96(3):699\u2013710","journal-title":"Kidney Int"},{"issue":"1","key":"2674_CR4","doi-asserted-by":"publisher","first-page":"126","DOI":"10.2215\/CJN.06910712","volume":"8","author":"R Mehrotra","year":"2013","unstructured":"Mehrotra R, Singh H (2013) Peritoneal dialysis-associated peritonitis with simultaneous exit-site infection. Clin J Am Soc Nephrol 8(1):126\u2013130","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"2674_CR5","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.2215\/CJN.00980112","volume":"7","author":"ATN van Diepen","year":"2012","unstructured":"van Diepen ATN, Tomlinson GA, Jassal SV (2012) The association between exit site infection and subsequent peritonitis among peritoneal dialysis patients. Clin J Am Soc Nephrol 7(8):1266\u20131271","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"2674_CR6","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3747\/pdi.2016.00078","volume":"36","author":"PKT Li","year":"2016","unstructured":"Li PKT, Szeto CC, Piraino B, de Arteaga J, Fan S, Figueiredo AE et al (2016) ISPD peritonitis recommendations: 2016 update on prevention and treatment. Perit Dial Int. 36(5):481\u2013508","journal-title":"Perit Dial Int."},{"issue":"7","key":"2674_CR7","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1128\/JCM.01834-08","volume":"47","author":"T Babu","year":"2009","unstructured":"Babu T, Rekasius V, Parada JP, Schreckenberger P, Challapalli M (2009) Mupirocin resistance among methicillin-resistant Staphylococcus aureus-colonized patients at admission to a tertiary care medical center. J Clin Microbiol 47(7):2279\u20132280","journal-title":"J Clin Microbiol"},{"issue":"6","key":"2674_CR8","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1177\/089686080102100604","volume":"21","author":"R Annigeri","year":"2001","unstructured":"Annigeri R, Conly J, Vas S, Dedier H, Prakashan KP, Bargman JM et al (2001) Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection. Perit Dial Int. 21(6):554\u2013559","journal-title":"Perit Dial Int."},{"issue":"1","key":"2674_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jgar.2013.10.002","volume":"2","author":"PY Hon","year":"2014","unstructured":"Hon PY, Koh TH, Tan TY, Krishnan P, Leong JW-Y, Jureen R et al (2014) Changing molecular epidemiology and high rates of mupirocin resistance among meticillin-resistant Staphylococcus aureus in Singaporean hospitals. J Glob Antimicrob Resist. 2(1):53\u201355","journal-title":"J Glob Antimicrob Resist."},{"issue":"7","key":"2674_CR10","doi-asserted-by":"publisher","first-page":"473","DOI":"10.5301\/ijao.5000207","volume":"36","author":"AK Al-Hwiesh","year":"2013","unstructured":"Al-Hwiesh AK, Abdul-Rahman IS, Al-Muhanna FA, Al-Sulaiman MH, Al-Jondebi MS, Divino-Filho JC (2013) Prevention of peritoneal dialysis catheter infections in Saudi peritoneal dialysis patients: the emergence of high-level mupirocin resistance. Int J Artif Organs 36(7):473\u2013483","journal-title":"Int J Artif Organs"},{"issue":"3","key":"2674_CR11","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3747\/pdi.2011.00224","volume":"32","author":"SJ Nessim","year":"2012","unstructured":"Nessim SJ, Jassal SV (2012) Gentamicin-resistant infections in peritoneal dialysis patients using topical gentamicin exit-site prophylaxis: a report of two cases. Perit Dial Int 32(3):339","journal-title":"Perit Dial Int"},{"issue":"5","key":"2674_CR12","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3747\/pdi.2011.00183","volume":"32","author":"DA Pierce","year":"2012","unstructured":"Pierce DA, Williamson JC, Mauck VS, Russell GB, Palavecino E, Burkart JM (2012) The effect on peritoneal dialysis pathogens of changing topical antibiotic prophylaxis. Perit Dial Int 32(5):525\u2013530","journal-title":"Perit Dial Int"},{"issue":"2","key":"2674_CR13","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1086\/524736","volume":"46","author":"RA Weinstein","year":"2008","unstructured":"Weinstein RA, Milstone AM, Passaretti CL, Perl TM (2008) Chlorhexidine: expanding the armamentarium for infection control and prevention. Clin Infect Dis 46(2):274\u2013281","journal-title":"Clin Infect Dis"},{"issue":"4","key":"2674_CR14","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0195-6701(93)90109-D","volume":"25","author":"AD Russell","year":"1993","unstructured":"Russell AD, Day MJ (1993) Antibacterial activity of chlorhexidine. J Hosp Infect 25(4):229\u2013238","journal-title":"J Hosp Infect"},{"issue":"12","key":"2674_CR15","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1001\/jama.2009.376","volume":"301","author":"J-F Timsit","year":"2009","unstructured":"Timsit J-F, Schwebel C, Bouadma L, Geffroy A, Garrouste-Orgeas M, Pease S et al (2009) Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically Ill adults. JAMA 301(12):1231","journal-title":"JAMA"},{"issue":"1","key":"2674_CR16","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1186\/s12879-019-4029-9","volume":"19","author":"L Wei","year":"2019","unstructured":"Wei L, Li Y, Li X, Bian L, Wen Z, Li M (2019) Chlorhexidine-impregnated dressing for the prophylaxis of central venous catheter-related complications: a systematic review and meta-analysis. BMC Infect Dis 19(1):429","journal-title":"BMC Infect Dis"},{"issue":"7","key":"2674_CR17","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1097\/CCM.0000000000000319","volume":"42","author":"N Safdar","year":"2014","unstructured":"Safdar N, O\u2019Horo JC, Ghufran A, Bearden A, Didier ME, Chateau D et al (2014) Chlorhexidine-impregnated dressing for prevention of catheter-related bloodstream infection: a meta-analysis*. Crit Care Med 42(7):1703\u20131713","journal-title":"Crit Care Med"},{"issue":"2017","key":"2674_CR18","first-page":"1","volume":"21","author":"K Shen","year":"2017","unstructured":"Shen K, Cho Y, Pascoe EM, Hawley CM, Oliver V, Hughes KM et al (2017) The SIESTA trial: a randomized study investigating the efficacy, safety, and tolerability of acupressure versus sham therapy for improving sleep quality in patients with end-stage kidney disease on hemodialysis. Evidence-Based Complement Altern Med 21(2017):1\u201310","journal-title":"Evidence-Based Complement Altern Med"},{"issue":"1","key":"2674_CR19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/BF00960091","volume":"14","author":"J Hunsley","year":"1992","unstructured":"Hunsley J (1992) Development of the treatment acceptability questionnaire. J Psychopathol Behav Assess 14(1):55\u201364","journal-title":"J Psychopathol Behav Assess"},{"issue":"2","key":"2674_CR20","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3747\/pdi.2016.00120","volume":"37","author":"C-C Szeto","year":"2017","unstructured":"Szeto C-C, Li PK-T, Johnson DW, Bernardini J, Dong J, Figueiredo AE et al (2017) ISPD catheter-related infection recommendations: 2017 update. Perit Dial Int. 37(2):141\u2013154","journal-title":"Perit Dial Int."},{"key":"2674_CR21","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1053\/j.ajkd.2017.10.017","volume":"71","author":"H Htay","year":"2017","unstructured":"Htay H, Cho Y, Pascoe EM, Darssan D, Nadeau-Fredette A-C, Hawley C et al (2017) Center effects and peritoneal dialysis peritonitis outcomes: analysis of a national registry. Am J Kidney Dis. 71:814\u2013821","journal-title":"Am J Kidney Dis."},{"key":"2674_CR22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3747\/pdi.2018.00056","volume":"39","author":"H Htay","year":"2018","unstructured":"Htay H, Seng JJB, Yong MHA, Pang SC, Wu SY, Chan CM et al (2018) Comparison of clinical presentation and outcomes of peritonitis in the elderly and younger peritoneal dialysis patients. Perit Dial Int. 39:163\u2013168","journal-title":"Perit Dial Int."},{"issue":"6","key":"2674_CR23","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3747\/pdi.2017.00028","volume":"37","author":"H Htay","year":"2017","unstructured":"Htay H, Cho Y, Pascoe EM, Darssan D, Hawley C, Clayton PA et al (2017) Outcomes of Corynebacterium peritonitis: a multicenter registry analysis. Perit Dial Int 37(6):619\u2013626","journal-title":"Perit Dial Int"},{"issue":"4","key":"2674_CR24","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3747\/pdi.2017.00199","volume":"38","author":"H Htay","year":"2018","unstructured":"Htay H, Cho Y, Pascoe EM, Hawley C, Clayton PA, Borlace M et al (2018) Outcomes of Acinetobacter peritonitis in peritoneal dialysis patients: a multicenter registry analysis. Perit Dial Int 38(4):257\u2013265","journal-title":"Perit Dial Int"},{"issue":"1","key":"2674_CR25","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1053\/j.ajkd.2019.09.016","volume":"76","author":"J Perl","year":"2020","unstructured":"Perl J, Fuller DS, Bieber BA, Boudville N, Kanjanabuch T, Ito Y et al (2020) Peritoneal dialysis-related infection rates and outcomes: results from the peritoneal dialysis outcomes and practice patterns study (PDOPPS). Am J Kidney Dis 76(1):42\u201353","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"2674_CR26","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3747\/pdi.2016.00257","volume":"37","author":"H Htay","year":"2017","unstructured":"Htay H, Johnson DW, Wu SY, Oei EL, Foo MWY, Choo JCJ (2017) Comparison of topical chlorhexidine and mupirocin for the prevention of exit-site infection in incident peritoneal dialysis patients. Perit Dial Int 37(3):266\u2013272","journal-title":"Perit Dial Int"},{"issue":"2","key":"2674_CR27","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/ki.1997.363","volume":"52","author":"CM Bunke","year":"1997","unstructured":"Bunke CM, Brier ME, Golper TA (1997) Outcomes of single organism peritonitis in peritoneal dialysis: Gram negatives versus gram positives in the network 9 peritonitis study. Kidney Int 52(2):524\u2013529","journal-title":"Kidney Int"},{"issue":"2","key":"2674_CR28","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1001\/jamadermatol.2013.903","volume":"149","author":"NA Weitz","year":"2013","unstructured":"Weitz NA, Lauren CT, Weiser JA, LeBoeuf NR, Grossman ME, Biagas K et al (2013) Chlorhexidine gluconate-impregnated central access catheter dressings as a cause of erosive contact dermatitis. JAMA Dermatol 149(2):195","journal-title":"JAMA Dermatol"},{"issue":"6","key":"2674_CR29","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1542\/peds.107.6.1431","volume":"107","author":"JS Garland","year":"2001","unstructured":"Garland JS, Alex CP, Mueller CD, Otten D, Shivpuri C, Harris MC et al (2001) A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics 107(6):1431\u20131436","journal-title":"Pediatrics"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-020-02674-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-020-02674-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-020-02674-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T08:58:01Z","timestamp":1633510681000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-020-02674-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,6]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["2674"],"URL":"https:\/\/doi.org\/10.1007\/s11255-020-02674-w","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,6]]},"assertion":[{"value":"1 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Htay Htay has received consultancy fees and travel sponsorships from AWAK Technologies Pte Ltd. She has also received speaker\u2019s honoraria and travel sponsorships from Baxter Healthcare. Marjorie Foo has received consultancy fees and travel sponsorships from AWAK Technologies Pte Ltd, and travel sponsorships from Baxter Healthcare. David Johnson has received grants from National Health and Medical Research Council of Australia, consultancy fees, research grants, speaker\u2019s honoraria and travel sponsorships from Baxter Healthcare and Fresenius Medical Care, consultancy fees from Astra Zeneca and AWAK, speaker\u2019s honoraria and travel sponsorships from ONO, and travel sponsorships from Amgen. All other authors have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by Singhealth Centralized Institutional Review Board (CIRB; reference number 2017\/2698).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all 50 participants in the pilot study. The CIRB granted a waiver of informed consent for the historical control group as non-interventional study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}